跳至主要内容
临床试验/IRCT2015101522173N2
IRCT2015101522173N2已完成2 期

Evaluation of comparison between Remifentanil infusion and single dose intravenous Hydralazine + Propranolol administration to provide controlled hypotension in patients undergoing Rhino plastic surgery in khalili hospital during 2014-2015

Shiraz University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
All

入选标准

  • Inclusion criterion: all patients in the range of 20-40 years old with class I ASA.
  • Exclusion criteria: patients in class II & III ASA; recent (the last 3 months) general anesthesia record; drug abuse; history of allergy to Propranolol or Hydralazine or Remifentanil; high blood pressure; cardiovascular diseases should be eliminated.

排除标准

  • 未提供

研究者

相似试验

Evaluation of comparison between Remifentanil... | 临床试验